Electrophysiology (EP) clinical teams require a unique set of technologies to perform accurate and safe exams. Toshiba America Medical Systems, Inc. offers these clinicians an InfinixTM-i cardiovascular X-ray system tailored for EP procedures with a new package of features, accessories and technologies

Amidst ongoing national debate about healthcare costs, new research unveiled today by Siemens Healthcare shows that the vast majority of Americans (92 percent) agree that “the value of knowing exactly what is wrong with their health is as important as having access to a doctor in the first place” and nearly four in five Americans (78 percent) would want to have a test done to diagnose a disease, even if there is no treatment or cure available.

Agfa HealthCare announces today that it has successfully implemented its DX-D 600 Direct Radiography (DR) system at Wrightington, Wigan and Leigh NHS Foundation Trust (WWL), creating a new DR room at the Leigh Infirmary.

Presence of posttraumatic stress disorder (PTSD) in young veterans increases odds of CT utilization more than 2.5 times, according to a study published in the May issue of Radiology.

The emergency department (ED) at Rhode Island Hospital is essentially a hospital within a hospital. Rhode Island Hospital’s ED is one of the largest emergency departments in the country with more than 101,000 visits per year. Our Andrew F. Anderson Emergency Center, which is a Level I trauma center, is equipped with five x-ray units within the five trauma rooms. Three additional x-ray units, two ultrasound rooms, two 64-slice CT scanners and a new MRI unit complete the imaging resources.

Amid the din of debates about screening mammography overuse, some women still remain underserved.

Carestream has been awarded a three-year agreement by Novation, a leading healthcare supply chain expertise and contracting company, to offer CARESTREAM Vue RIS+PACS, CARESTREAM Cardiology PACS and CARESTREAM Vue for Vendor-Neutral Archive to the members Novation serves.

Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women, today announced the publication of the final results of a large-scale prospective study comparing breast cancer screening using Hologic’s 2D mammography plus tomosynthesis (Breast Tomosynthesis) with conventional 2D mammography published online in advance of print by The Lancet Oncology.